newsfilter
← Latest News
GlobeNewswire·

Atea Pharmaceuticals Added to the Nasdaq Biotechnology Index

BOSTON, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) ("Atea"), a clinical-stage biopharmaceutical company, today announced that the company has been added to the NASDAQ Biotech Index (NASDAQ:NBI), effective prior to market